It’s no secret that CGM is quickly becoming the standard for glucose measurement. As we have noted it won’t be long before Time in Range (TIR) joins HbA1c as a metric for measuring what is and what is not good control. While HbA1c will likely remain the de facto gold standard for non-insulin using patients, TIR combined with HbA1c will become the standard for insulin using patients. Although this metric combination has not yet been officially recognized many physicians are already using it.
This move towards combining metrics has some serious implications for the growing CGM market . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.